Puylaert Kevin
SEC CIK 2119354 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SOPH | SOPHiA GENETICS SA | Chief Sales Off | 147.9K | — | $4,608 | 8 | 2026-03-19 | 2026-07-06 |
Most active insiders at SOPH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Camblong Jurgi | Executive COB, Dir | — | $2.34M |
| 2 | Xu Zhenyu | CSO | — | $725.3K |
| 3 | Menu Philippe | Chief Medical Off | — | $442.5K |
| 4 | Verma Abhimanyu | CTO | — | $240.2K |
| 5 | Muken Ross | Pres | — | $169.7K |
| 6 | CARDOZA GEORGE | CFO | $99.0K | $53.5K |
| 7 | Valente Manuela | CHRO | — | $149.1K |
| 8 | HIBBS KATHY L | Dir | — | $140.1K |
| 9 | Van Well Daan | CLO | — | $116.4K |
| 10 | Puylaert Kevin | Chief Sales Off | — | $4,608 |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-07-07 16:03 | 2026-07-06 | SOPH | SOPHiA GENETICS SA | Puylaert Kevin | Chief Sales Off | S - Sale | $5.03 | -216 | 147.9K | -0.1% | -$1,087 |
| 2026-05-20 16:02 | 2026-05-19 | SOPH | SOPHiA GENETICS SA | Puylaert Kevin | Chief Sales Off | S - Sale | $4.54 | -33 | 148.2K | -0.0% | -$149.90 | |
| 2026-04-21 16:04 | 2026-04-20 | SOPH | SOPHiA GENETICS SA | Puylaert Kevin | Chief Sales Off | S - Sale | $5.08 | -33 | 148.2K | -0.0% | -$167.69 | |
| M | 2026-04-08 16:05 | 2026-04-06 | SOPH | SOPHiA GENETICS SA | Puylaert Kevin | Chief Sales Off | S - Sale | $4.86 | -624 | 148.2K | -0.4% | -$3,032 |
| DA | 2026-04-08 08:47 | 2026-04-02 | SOPH | SOPHiA GENETICS SA | Puylaert Kevin | Chief Sales Off | A - Grant | $0.00 | +56.5K | 148.9K | +61% | $0 |
| D | 2026-04-03 06:59 | 2026-04-02 | SOPH | SOPHiA GENETICS SA | Puylaert Kevin | Chief Sales Off | A - Grant | $0.00 | +56.5K | 56.5K | New | $0 |
| 2026-04-01 10:41 | 2026-03-31 | SOPH | SOPHiA GENETICS SA | Puylaert Kevin | Chief Sales Off | S - Sale | $4.71 | -3 | 92.4K | -0.0% | -$14.13 | |
| 2026-03-20 | 2026-03-19 | SOPH | SOPHiA GENETICS SA | Puylaert Kevin | Chief Sales Off | S - Sale | $4.76 | -33 | 92.4K | -0.0% | -$157.08 |
Purchase Sale Sale after option exercise All abbreviations